Affiliation: Ohio State University

Dr. Gina Sizemore is an assistant professor in the Department of Radiation Oncology at The Ohio State University School of Medicine, and a member of the Cancer Biology Program at The OSU-James Comprehensive Cancer Center. Dr. Sizemore’s research program integrates in vitro cell line and in vivo mouse modeling of the breast metastatic tumor microenvironment (TME) to provide mechanistic insight into breast cancer progression. Dr. Sizemore earned her BA in Biology at Washington and Jefferson College in 2003 and then spent two years as a research assistant for Dr. Dennis Slamon at the University of California, Los Angeles. She then matriculated to Case Western Reserve University in 2005 where she earned her PhD in Pharmacology in 2012 under Dr. Ruth Keri. After serving as a postdoctoral scholar there for about a year, Dr. Sizemore moved to OSU to gain expertise in the TME in the lab of Dr. Michael Ostrowski. There, from 2013-17 she was both a Pelotonia and Department of Defense Breast Cancer Research Program postdoctoral fellow. Following receipt of a K22 Transition Career Development Award from the National Cancer Institute in 2017, she then transitioned to tenure-track faculty in the Department of Radiation Oncology. Dr. Sizemore has been awarded numerous awards and fellowships over her career, including a METAvivor Young Investigator Award and the Herbert and Maxine Block Lectureship Junior Faculty Award. She has also authored/co-authored articles in prestigious journals including Nature Communications, Genes and Development, Molecular Cancer Research, Oncogene and The Journal of Biological Chemistry.